Is NRC Health (NRC) a Buy, Sell, or Hold?
NASDAQ : NRC
NRC Health
$19.51 USD
$0.6 (3.17%)
- Volume
- 166.86K
- Average Volume
- 125.31K
- Market Capitalization
- $439.69M
- P/E Ratio
- 74.32
- Dividend Yield
- 3.08%
- Price Target
- Year High
- $23.68
- Year Low
- $11.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $2.17
- Current Ratio
- $0.65
Company Overview
NASDAQ
Trent Green
Medical - Healthcare Information Services
Healthcare
NRC
357
US
USD
Liquidity Metrics
13.75
0.65
0.65
0.10
2.17
Sales & Valuation
$137.39M
3.14
65.57
20.32
0.98
Profitability
$0.52
$11.6M
4.18%
6.70%
48.46%
4.30%
P/E Metrics
74.32
-1.12
-1.12
Analyst Price Target & Rating
3/5
1 Analysts
%
Financial Health Scores
3.00
6/9
-$12.21M
$136.15M
$129.6M
$14.77M
Key Metrics (TTM)
$526.39M
3.76
22.50
0.65
48.46%
8.75%
1.36%
4.92%
$1.33
-15 days
Company Executives
| Name | Title |
|---|---|
| Shane R. Harrison | Executive VP, CFO, Treasurer & Secretary |
| Andrew Monnich | EVP & Chief Corporate Development Officer |
| David Burik | Executive Vice President of Strategic Insights |
| Jennifer Baron | Chief Experience Officer |
| Trent Green | CEO, Principal Executive Officer & Director |
| Helen L. Hrdy | EVP & COO |
| Jason R. Rau | Executive Vice President of Sales |
| Michael D. Hays | Founder & Chairman |
| Jordan N. Freeman | Chief Accounting Officer |
Poll Results
No votes yet today — be the first to share your view!
About NRC Health (NASDAQ:NRC) Stock
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Sp ... ecialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
NRC Health (NRC) Q2 2026 Earnings Call Transcript
2026-07-29 00:53:11
NRC Health (NRC) Q2 2026 Earnings Call Transcript
National Research Q2 Earnings Call Highlights
2026-07-28 18:07:33
National Research NASDAQ: NRC, operating as NRC Health, reported second-quarter results marked by 11% year-over-year growth in total recurring contract value, while management said investments in implementation, customer success and product development supported a large customer deployment and future growth initiatives.
NRC Health Announces Second Quarter 2026 Results
2026-07-28 16:00:00
LINCOLN, Neb.--(BUSINESS WIRE)--NRC Health (NASDAQ: NRC), a leader in healthcare experience improvement solutions, today announced results for the second quarter 2026. "Our second quarter was a success on many fronts, including double-digit TRCV growth over the prior year, strong go-to-market and solutions delivery execution, continued commercialization of our product innovations, and the strongest bookings performance for The Governance Institute in seven years, positioning us well for a stron.
Nations Royalty Reports Fiscal 2026 Year-End Results and Provides Portfolio Update
2026-07-28 08:30:00
Vancouver, British Columbia--(Newsfile Corp. - July 28, 2026) - Nations Royalty Corp. (TSXV: NRC) (OTCQX: NRYCF) (FSE: Y96) ("Nations Royalty" or the "Company") is pleased to report financial results for the year ended March 31, 2026, and provide an update on key assets within its royalty portfolio. Highlights for Fiscal 2026 Royalty revenue increased 91% year-over-year to C$1.61 million, compared to C$0.84 million in Fiscal 2025.
90,182 Shares in National Research Corporation $NRC Bought by Fifth Third Bancorp
2026-07-24 04:05:14
Fifth Third Bancorp acquired a new stake in shares of National Research Corporation (NASDAQ: NRC) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 90,182 shares of the company's stock, valued at approximately $1,531,000. Fifth Third Bancorp owned approximately
2026-07-23 08:00:00
Voluntary NRC readiness review to support 2026 SOLO™ Construction Permit Application and Terra's 2028 commercialization target Early review of draft safety and environmental documentation intended to identify issues in advance of formal submittal and strengthen application quality Preapplication engagement aligns with Terra's parallel construction permit and operating license strategy NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. (NASDAQ: NKLR) (“Terra” or the “Company”), a developer of advanced micro-modular nuclear reactors, today announced that it has requested that the U.S. Nuclear Regulatory Commission (“NRC”) conduct a voluntary preapplication readiness review of the Company's planned SOLO™ Micro-Modular Reactor (“MMR™”) Construction Permit Application.
Constellation Seeks License Renewals for Two New York Units Through 2049
2026-06-26 12:00:00
Constellation (Nasdaq: CEG) has filed license renewal applications with the Nuclear Regulatory Commission (NRC) to extend the operations of Ginna Clean Energy
2026-06-25 08:00:00
Meeting with NRC kicks off review activities and marks continued regulatory progress following acceptance of the KRONOS MMR ™ Construction Permit Application and supports previously disclosed expectations for initial construction activities to begin in the second half of 2027 New York, N.Y., June 25, 2026 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear micro modular reactor and technology company focused on developing clean energy solutions, today announced continued progress in the U.S. Nuclear Regulatory Commission's (“NRC”) review of the Construction Permit Application (“CPA”) for deployment of NANO Nuclear's KRONOS MMR ™ Energy System at the University of Illinois Urbana-Champaign (“U.
Frequently Asked Questions
-
What is the current NRC Health (NRC) stock price?
-
NRC Health(NASDAQ:NRC) stock price is $19.51 in the last trading session. During the trading session, NRC stock reached the peak price of $23.68 while $11.014 was the lowest point it dropped to. The percentage change in NRC stock occurred in the recent session was 3.17% while the dollar amount for the price change in NRC stock was $0.6.
-
NRC's industry and sector of operation?
-
The NASDAQ listed NRC is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of NRC?
-
Shane R. Harrison | Executive VP, CFO, Treasurer & Secretary
Andrew Monnich | EVP & Chief Corporate Development Officer
David Burik | Executive Vice President of Strategic Insights
Jennifer Baron | Chief Experience Officer
Trent Green | CEO, Principal Executive Officer & Director -
How many employees does NRC have?
-
Number of NRC employees currently stands at 357. NRC operates from 1245 Q Street, Lincoln, NE 68508, US.
-
Link for NRC official website?
-
Official Website of NRC is: https://nrchealth.com
-
How do I contact NRC?
-
NRC could be contacted at phone #402 475 2525 and can also be accessed through its website. NRC operates from 1245 Q Street, Lincoln, NE 68508, US.
-
How many shares of NRC are traded daily?
-
The average number of NRC shares traded daily for last 3 months was 125.31K.
-
What is the market cap of NRC currently?
-
The market value of NRC currently stands at $439.69M with its latest stock price at $19.51